Ann

Ann Becker, Borsbeek BE

Patent application number	Description	Published
20110034655	Process for Producing Water-Absorbing Polymer Particles - A process for producing water-absorbing polymer particles, wherein a polymer gel is removed from a polymerization reactor, stored intermediately as a particulate polymer gel in a delay vessel, removed by means of a first conveying device at the lower end of the delay vessel and dried, the intermediately stored particulate polymer gel being conveyed within the delay vessel by means of at least one second conveying device above the first conveying device in the direction of the first conveying device.	02-10-2011
20110098416	Method for the Continuous Thermal Secondary Surface Cross-Linking of Water-Absorbing Polymer Particles - A process for continuous thermal postcrosslinking of water-absorbing polymer particles, wherein the postcrosslinker is applied to the water-absorbing polymer particles by means of suitable nozzles and the nozzles are exchanged or cleaned via the interior of a glovebox adjoining the plant section comprising the nozzle.	04-28-2011
20130058837	PROCESS FOR PRODUCING WATER-ABSORBING POLYMER PARTICLES - A process for producing water-absorbing polymer particles, wherein a polymer gel is removed from a polymerization reactor, stored intermediately as a particulate polymer gel in a delay vessel, removed by means of a first conveying device at the lower end of the delay vessel and dried, the intermediately stored particulate polymer gel being conveyed within the delay vessel by means of at least one second conveying device above the first conveying device in the direction of the first conveying device.	03-07-2013

Ann Bergeret, Ales FR

Patent application number	Description	Published
20080199697	Reinforcing Yarns and Composites with an Improved Fire-Resistance - The present invention relates to a composition for reinforcing strands, characterized in that it includes at least one additive capable of acting at the strands/matrix interface so as to improve the fire resistance of the strands/matrix composite, and it also relates to the strands and composites obtained.	08-21-2008

Ann Bolcavage, Indianapolis, IN US

Patent application number	Description	Published
20080213617	Coated articles - This invention relates to articles coated with a thermally sprayed coating of a high purity yttria or ytterbia stabilized zirconia powder, said high purity yttria or ytterbia stabilized zirconia powder comprising from about 0 to about 0.15 weight percent impurity oxides, from about 0 to about 2 weight percent hafnium oxide (hafnia), from about 6 to about 25 weight percent yttrium oxide (yttria) or from about 10 to about 36 weight percent ytterbium oxide (ytterbia), and the balance zirconium oxide (zirconia). The articles include, for example, blades, vanes and seal surfaces of gas turbine engines coated with a thermal barrier coating.	09-04-2008
20080220209	Thermally sprayed coatings - This invention relates to thermally sprayed coatings of a high purity yttria or ytterbia stabilized zirconia powder, said high purity yttria or ytterbia stabilized zirconia powder comprising from about 0 to about 0.15 weight percent impurity oxides, from about 0 to about 2 weight percent hafnium oxide (hafnia), from about 6 to about 25 weight percent yttrium oxide (yttria) or from about 10 to about 36 weight percent ytterbium oxide (ytterbia), and the balance zirconium oxide (zirconia). Thermal barrier coatings for protecting a component such as blades, vanes and seal surfaces of gas turbine engines, made from the high purity yttria or ytterbia stabilized zirconia powders, have a density greater than 88% of the theoretical density with a plurality of vertical macrocracks homogeneously dispersed throughout the coating to improve its thermal fatigue resistance.	09-11-2008
20110014060	Substrate Features for Mitigating Stress - An article may include an array of features formed in a substrate and may be coated with a coating layer. The array of features may mitigate stress experienced by the coated article. In particular, the array of features may reduce or limit crack propagation at the interface between the substrate and the coating layer. In some examples, the article is an airfoil that includes a tip that defines an edge. An array of features is formed on the surface of the tip, where the array of features is proximate to the edge, and the array of features does not intersect the edge. The airfoil includes a coating layer formed on the surface of the tip and the array of features.	01-20-2011
20110097538	Substrate Features for Mitigating Stress - An article may include an array of features formed in a substrate and may be coated by a thermal barrier coating (TBC). The array of features may mitigate thermal stress experienced by the coated article. In particular, the array of features may reduce or limit crack propagation at or above the interface of a thermally insulative layer and a bond coat in the TBC. In some embodiments, the array may be formed proximate to and substantially aligned with cooling holes formed in the substrate. In other embodiments, an article may include a first array of features formed in a first location of a substrate and a second array of features formed in a second location of a substrate. The first and second locations may be determined or selected based on a prediction of thermal stresses that the substrate will experience at the first and second locations during use.	04-28-2011
20120003102	DENSE VERTICALLY CRACKED THERMAL BARRIER COATINGS - This invention relates to dense, vertically cracked thermal barrier coatings made from high purity yttria or ytterbia stabilized zirconia powders. The high purity yttria or ytterbia stabilized zirconia powder consisting essentially of less than about 0.01 weight percent silicon dioxide (silica), less than about 0.002 weight percent aluminum oxide (alumina), less than about 0.005 weight percent calcium oxide, less than about 0.005 weight percent ferric oxide, less than about 0 to about 0.002 weight percent magnesium oxide, less than about 0 to about 0.005 weight percent titanium dioxide, from about 1.5 to about 2 weight percent hafnium oxide (hafnia), from about 6 to about 25 weight percent yttrium oxide (yttria), less than 0.1 weight percent other impurity oxides, and the balance zirconium oxide (zirconia) and the balance zirconium oxide (zirconia). The thermal barrier coatings are intended to be used in cyclic thermal environments such as for gas turbine blades, vanes and seal surfaces exposed in the hot section of gas turbine engines.	01-05-2012
20120122651	High purity powders - This invention relates to high purity yttria or ytterbia stabilized zirconia powders comprising from about 0 to about 0.15 weight percent impurity oxides, from about 0 to about 2 weight percent hafnium oxide (hafnia), from about 6 to about 25 weight percent yttrium oxide (yttria) or from about 10 to about 36 weight percent ytterbium oxide (ytterbia), and the balance zirconium oxide (zirconia). Thermal barrier coatings for protecting a component such as blades, vanes and seal surfaces of gas turbine engines, made from the high purity yttria or ytterbia stabilized zirconia powders, have a density greater than 88% of the theoretical density with a plurality of vertical macrocracks homogeneously dispersed throughout the coating to improve its thermal fatigue resistance.	05-17-2012
20130330507	HIGH PURITY ZIRCONIA-BASED THERMALLY SPRAYED COATINGS AND PROCESSES FOR THE PREPARATION THEREOF - This invention relates to thermally sprayed coatings of a high purity yttria or ytterbia stabilized zirconia powder, said high purity yttria or ytterbia stabilized zirconia powder comprising from about 0 to about 0.15 weight percent impurity oxides, from about 0 to about 2 weight percent hafnium oxide (hafnia), from about 6 to about 25 weight percent yttrium oxide (yttria) or from about 10 to about 36 weight percent ytterbium oxide (ytterbia), and the balance zirconium oxide (zirconia). Thermal barrier coatings for protecting a component such as blades, vanes and seal surfaces of gas turbine engines, made from the high purity yttria or ytterbia stabilized zirconia powders, have a density greater than 88% of the theoretical density with a plurality of vertical macrocracks homogeneously dispersed throughout the coating to improve its thermal fatigue resistance.	12-12-2013
20140134455	INTERFACIAL DIFFUSION BARRIER LAYER INCLUDING IRIDIUM ON A METALLIC SUBSTRATE - An article may include a substrate, a diffusion barrier layer formed on the substrate, and a protective layer formed on the diffusion barrier coating. The diffusion barrier layer may include iridium.	05-15-2014
20140147696	ALLOY WITH ION BOMBARDED SURFACE FOR ENVIRONMENTAL PROTECTION - An article may include a substrate that comprises a nickel alloy. The substrate may include a modified subsurface region and a bulk region. The modified subsurface region may include a first composition and the bulk region may include a second composition different than the first composition. The modified subsurface region may include at least one of a reactive element or a noble metal, and the modified subsurface region comprises a thickness of less than about 0.3 μm measured in a direction substantially normal to a surface of the substrate. The modified subsurface region may be formed by depositing a layer including at least one of the reactive element or the noble metal in a layer on a surface of the substrate and introducing the at least one of the reactive element or the noble metal into the modified subsurface region using ion bombardment.	05-29-2014
20140178632	HIGH PURITY ZIRCONIA-BASED THERMALLY SPRAYED COATINGS AND PROCESSES FOR THE PREPARATION THEREOF - This invention relates to thermally sprayed coatings of a high purity yttria or ytterbia stabilized zirconia powder, said high purity yttria or ytterbia stabilized zirconia powder comprising from about 0 to about 0.15 weight percent impurity oxides, from about 0 to about 2 weight percent hafnium oxide (hafnia), from about 6 to about 25 weight percent yttrium oxide (yttria) or from about 10 to about 36 weight percent ytterbium oxide (ytterbia), and the balance zirconium oxide (zirconia). Thermal barrier coatings for protecting a component such as blades, vanes and seal surfaces of gas turbine engines, made from the high purity yttria or ytterbia stabilized zirconia powders, have a density greater than 88% of the theoretical density with a plurality of vertical macrocracks homogeneously dispersed throughout the coating to improve its thermal fatigue resistance.	06-26-2014
20140334939	HIGH PURITY POWDERS - This invention relates to high purity yttria or ytterbia stabilized zirconia powders comprising from about 0 to about 0.15 weight percent impurity oxides, from about 0 to about 2 weight percent hafnium oxide (hafnia), from about 6 to about 25 weight percent yttrium oxide (yttria) or from about 10 to about 36 weight percent ytterbium oxide (ytterbia), and the balance zirconium oxide (zirconia). Thermal barrier coatings for protecting a component such as blades, vanes and seal surfaces of gas turbine engines, made from the high purity yttria or ytterbia stabilized zirconia powders, have a density greater than 88% of the theoretical density with a plurality of verticalzA macrocracks homogeneously dispersed throughout the coating to improve its thermal fatigue resistance.	11-13-2014

Ann Boriack-Sjodin, Waltham, MA US

Patent application number	Description	Published
20100137313	HETEROCYCLIC DERIVATIVES AND METHODS OF USE THEREOF - Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.	06-03-2010

Ann Bowar, Wilmette, IL US

Patent application number	Description	Published
20110117809	PLUSH TOY - The present invention generally relates to a plush toy, including a fabric encasement and various smaller, collectible plush items that can be stored therein. Specifically, it is an object of the present invention to provide a plush toy that reflects the individuality its owner by providing a fabric encasement for retaining a plurality of smaller individually selected plush items that collectively represent a particular individual, wherein the smaller plush items are insertable into the cavity of the encasement to form filling thereof. Therefore, each smaller plush item represents an aspect of user's personality, identity, interests or life experiences via a photographic representation, iconic graphic, or image provided by the user. The collection of smaller plush items held by the fabric encasement represents a particular individual. The present invention fosters creativity, self empowerment, reflection and allows a user to participate in the creation of a unique toy.	05-19-2011

Ann Brigé, Ertvelde BE

Patent application number	Description	Published
20110091462	NOVEL ANTIGEN BINDING DIMER-COMPLEXES, METHODS OF MAKING AND USES THEREOF - In a broad aspect the present invention generally relates to novel dimer-complexes (herein called “non-fused-dimers” or NFDs) comprising single variable domains, methods of making these complexes and uses thereof. These non-covalently bound dimer-complexes consist of two identical monomers that each comprises of one or more single variable domains (homodimers) or of two different monomers that each comprises on or more single variable domains (heterodimers). The subject NFDs have typically altered e.g. improved binding characteristics over their monomeric counterpart. The NFDs of the invention may further be engineered through linkage by a flexible peptide or cysteines in order to improve the stability. This invention also describes conditions under which such NFDs are formed and conditions under which the formation of such dimers can be avoided.	04-21-2011
20110117113	IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN DIRECTED AGAINST HUMAN CXCR4 AND OTHER CELL ASSOCIATED PROTEINS AND METHODS TO GENERATE THEM - The invention relates to immunoglobulin single variable domains directed against specific human CXCR4 epitopes (herein also referred to interchangeably as “compounds of the invention”, “amino acid sequences of the invention”, or “building blocks of the invention”) and polypeptides comprising them (herein also referred to as “polypeptides of the invention”, “compounds of the invention”, or “constructs of the invention”).	05-19-2011
20120093839	NOVEL ANTIGEN BINDING DIMER-COMPLEXES, METHODS OF MAKING/AVOIDING AND USES THEREOF - In a broad aspect the present invention generally relates to novel dimer-complexes (herein called “non-fused-dimers” or NFDs) comprising single variable domains, methods of making these complexes and uses thereof. These non-covalently bound dimer-complexes consist of two identical monomers that each comprises of one or more single variable domains (homodimers) or of two different monomers that each comprises on or more single variable domains (heterodimers). The subject NFDs have typically altered e.g. improved binding characteristics over their monomelic counterpart. The NFDs of the invention may further be engineered through linkage by a flexible peptide or cysteines in order to improve the stability. This invention also describes conditions under which such NFDs are formed and conditions under which the formation of such dimers can be avoided.	04-19-2012
20120201812	STABLE FORMULATIONS OF POLYPEPTIDES AND USES THEREOF - Stable formulations are provided that contain immunoglobulin single variable domains at a high concentration. The formulations are useful as pharmaceutical formulation and suitable for subcutaneous administration. The formulations can be transported and stored under various stress conditions. The invention further relates to containers and pharmaceutical units comprising such formulations and to methods for preparing and prophylactic and therapeutic uses of the formulations and pharmaceutical units of the invention.	08-09-2012
20120225072	STABLE FORMULATIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF - The present invention relates to stable formulations of polypeptides, e.g. immunoglobulin single variable domains.	09-06-2012
20120244158	STABLE FORMULATIONS OF POLYPEPTIDES AND USES THEREOF - Formulations are provided that contain single variable domains with a good solubility and good stability under different storage, transportation and stress conditions. The formulations are useful as pharmaceutical formulation. The formulation comprises an aqueous carrier with a pH of 5.5 to 8.0, a buffer selected from the group consisting of histidine pH 6.0-6.5, hepes pH 7.0-8.0, MES pH 6.0, succinate pH 6.0-6.5 and acetate pH 5.5-6.0; an excipient; and/or a surfactant selected from Tween 80, Tween 20 and poloxamers. The formulation is further characterized that it has an inorganic salt concentration of 150 mM or lower. The invention further relates to containers and pharmaceutical units comprising such formuSations and to methods for preparing and prophylactic and therapeutic uses of the formulations and pharmaceutical units of the invention.	09-27-2012
20130261288	METHOD FOR THE PRODUCTION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS - The present disclosure relates to an improved method for the manufacture of immunoglobulin single variable domains. More specifically, the present disclosure relates to a method of producing immunoglobulin single variable domains in which the proportion of carbamylated variants is strongly reduced or absent and to improved immunoglobulin single variable domains obtainable by methods of the present disclosure.	10-03-2013
20140141507	METHOD FOR THE PRODUCTION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS - Methods are provided for the expression of immunoglobulin variable domains that are secreted into the culture medium. The methods provide for the production of homogeneous immunoglobulin variable domains in which the proportion of product-related variants that comprise, at the N-terminus, at least one redundant amino acid residue derived from the secretion signal is strongly reduced or absent.	05-22-2014
20140178383	STABLE FORMULATIONS OF POLYPEPTIDES AND USES THEREOF - Formulations are provided that contain single variable domains with a good solubility and good stability under different storage, transportation and stress conditions. The formulations are useful as pharmaceutical formulation. The formulation comprises an aqueous carrier with a pH of 5.5 to 8.0, a buffer selected from the group consisting of histidine pH 6.0-6.5, hepes pH 7.0-8.0, MES pH 6.0, succinate pH 6.0-6.5 and acetate pH 5.5-6.0; an excipient; and/or a surfactant selected from Tween 80, Tween 20 and poloxamers. The formulation is further characterized that it has an inorganic salt concentration of 150 mM or lower.	06-26-2014

Ann Brigé, Ertvelde BE

Patent application number	Description	Published
20110091462	NOVEL ANTIGEN BINDING DIMER-COMPLEXES, METHODS OF MAKING AND USES THEREOF - In a broad aspect the present invention generally relates to novel dimer-complexes (herein called “non-fused-dimers” or NFDs) comprising single variable domains, methods of making these complexes and uses thereof. These non-covalently bound dimer-complexes consist of two identical monomers that each comprises of one or more single variable domains (homodimers) or of two different monomers that each comprises on or more single variable domains (heterodimers). The subject NFDs have typically altered e.g. improved binding characteristics over their monomeric counterpart. The NFDs of the invention may further be engineered through linkage by a flexible peptide or cysteines in order to improve the stability. This invention also describes conditions under which such NFDs are formed and conditions under which the formation of such dimers can be avoided.	04-21-2011

Ann Cassidy-Stone, Davis, CA US

Patent application number	Description	Published
20080287473	NOVEL MOLECULES FOR REGULATING CELL DEATH - The present invention provides compounds capable of regulating apoptosis, e.g., via regulating mitochondrial fission or fusion. The present invention also provides methods of screening for compounds capable of regulating apoptosis and methods of treating conditions association with apoptosis.	11-20-2008

Ann Caston-Balderrama, San Pedro, CA US

Patent application number	Description	Published
20090137056	METHODS FOR DETECTING DIHYDROXYVITAMIN D METABOLITES BY MASS SPECTROMETRY - Provided are methods of detecting the presence or amount of a dihydroxyvitamin in D metabolite in a sample using mass spectrometry. The methods generally comprise ionizing a dihydroxyvitamin D metabolite in a sample and detecting the amount of the ion to determine the presence or amount of the vitamin D metabolite in the sample. In certain preferred embodiments the methods include immunopurifying the dihydroxyvitamin D metabolites prior to mass spectrometry. Also provided are methods to detect the presence or amount of two or more dihydroxyvitamin D metabolites in a single assay.	05-28-2009

Ann Chahroudi, Atlanta, GA US

Patent application number	Description	Published
20090263830	VISUALIZATION AND QUANTITIATION OF CELLULAR CYTOTOXICITY USING CELL-PERMEABLE FLUOROGENIC PROTEASE SUBSTRATES AND CASPASE ACTIVITY INDICATOR MARKERS - This invention provides a non-radioactive assay to monitor and quantify the target-cell killing activities mediated by cytotoxic T lymphocytes (CTLs). This assay is predicated on the discovery that apoptosis pathway activation and, in particular, caspase activity, provides a measure of cytotoxic effector cell activity. In one embodiment, measurement of CTL-induced caspase activation in target cells is achieved through detection of the specific cleavage of fluorogenic caspase substrates. This assay reliably detects antigen-specific CTL killing of target cells, and provides a more sensitive, more informative and safer alternative to the standard	10-22-2009

Ann Chen, Taipei City TW

Patent application number	Description	Published
20100081142	BIOMARKERS FOR KIDNEY DISEASES AND METHOD FOR USING SAME - The present invention provides biomarkers for detecting kidney disease, selected from the oligonucleotide sequence, complementary sequence or derivatives, amino acid sequence or derivatives, fragment, variants, antibody of annexin A2 or S100A6 or combinations thereof. Moreover, the present invention also provides an assay kit and a method for kidney disease detecting, practically for the kidney disease resulting from acute tubular necrosis.	04-01-2010
20110183349	BIOMARKERS FOR IgA NEPHROPATHY AND APPLICATIONS THEREOF - The present invention provides a method for diagnosis or prognosis of IgA nephropathy in a subject based on detection of the expression level of one or more biomarker genes selected from the group consisting of thymosin β4 (Tmsb4), serine or cysteine proteinase inhibitor clade E member 2 (Serpine2), secreted phosphoprotein 1 (OPN), butyrophilin-like-2 (BTNL2), S100 calcium binding protein A8 (S100A8), Cystatin C (CysC), and any combination thereof.	07-28-2011
20120129175	METHOD FOR RENAL DISEASE DIAGNOSIS AND PROGNOSIS USING ANNEXIN A1 AND RAB23 AS MARKERS - Use of Annexin A1 or Rab23 as a biomarker for diagnosing kidney disease or assessing efficacy of kidney disease treatment.	05-24-2012
20120189719	SCHISANDRAE FRUCTUS EXTRACTS FOR INHIBITION OR PREVENTION OF H1N1 INFLUENZA VIRUS INFECTION AND ITS APPLICATION THEREOF - Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.	07-26-2012
20120196287	Tmsb4 as a Biomarker for IgA Nephropathy - The present invention provides a method for diagnosis or prognosis of IgA nephropathy in a subject based on detection of the expression level of one or more biomarker genes selected from the group consisting of thymosin β4 (Tmsb4), serine or cysteine proteinase inhibitor clade E member 2 (Serpine2), secreted phosphoprotein 1 (OPN), butyrophilin-like-2 (BTNL2), S100 calcium binding protein A8 (S100A8), Cystatin C (CysC), and any combination thereof.	08-02-2012
20120309821	Use of epigallocatechin-3-gallate for immune regulation - The preset invention relates to a method for treating lupus erythematosus, particularly lupus nephritis, comprising administering a subject in need thereof a therapeutically effective amount of epigallocatechin-3-gallate (EGCG) or a pharmaceutically acceptable salt or a physiologically functional derivative, together with one or more pharmaceutically acceptable carriers, diluents or excipients.	12-06-2012
20130101998	METHOD FOR DIAGNOSING KIDNEY DISEASE COMPRISING DETECTING THE LEVEL OF ANNEXIN A2 OR S100A6 - The present invention provides biomarkers for detecting kidney disease, selected from the oligonucleotide sequence, complementary sequence or derivatives, amino acid sequence or derivatives, fragment, variants, antibody of annexin A2 or S100A6 or combinations thereof. Moreover, the present invention also provides an assay kit and a method for kidney disease detecting, practically for the kidney disease resulting from acute tubular necrosis.	04-25-2013
20130323750	Method for Analyzing Apoptosis Inducing Factor-2 - A method for analyzing apoptosis inducing factor-2 (AIF-2) is disclosed, which has not been found in urine samples of human patients with chronic kidney disease, to establish AIF-2 as a non-invasive biomarker for chronic kidney disease. The method includes: collecting a plurality of urine samples; conducting western blot for each urine sample for detecting the AIF-2 protein content in each urine sample; and conducting statistical analysis of the AIF-2 protein content in each urine sample to establish AIF-2 as a biological marker for chronic kidney disease.	12-05-2013

Ann Chen, Taipei TW

Patent application number	Description	Published
20100203512	METHOD FOR RENAL DISEASE DIAGNOSIS AND PROGNOSIS USING ANNEXIN A1 AND RAB23 AS MARKERS - Use of Annexin A1 or Rab23 as a biomarker for diagnosing kidney disease or assessing efficacy of kidney disease treatment.	08-12-2010
20130171275	USE OF BAMBOO VINEGAR FOR TREATING INFLAMMATION - The preset invention relates to a method for treating inflammation comprising administering a subject in need thereof with a therapeutically effective amount of a composition comprising bamboo vinegar or the phenolic fraction thereof. The method for preparing the phenolic fraction is also provided.	07-04-2013
20140343167	USE OF CITRAL FOR TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS - The present invention relates to a new use of citral for manufacturing a medicament for treating focal segmental glomerulosclerosis (FSGS). Particularly, the present invention discloses that citral is effective in alleviating symptoms of FSGS, including reducing glomerular epithelial hyperplasia lesions (EPHLs), peri-glomerular inflammation or glomerular hyalinosis or sclerosis, and also reducing proteinuria or hematuria or lowering serum urea nitrogen level or serum creatinine level in the subject.	11-20-2014

Ann Chidgey, Black Rock AU

Patent application number	Description	Published
20100178700	NOVEL THYMIC CELLULAR POPULATIONS AND USES THEREOF - The present invention relates generally to novel thymic cellular populations and, more particularly, to novel thymic epithelial cellular populations. Most particular, the present invention is directed to novel thymic epithelial progenitor cell populations. The cellular populations of the present invention are useful in a wide range of clinical and research settings including, inter alia, the in vitro or in vivo generation of thymic epithelial cell populations and the therapeutic or prophylactic treatment of a range of conditions via the administration of these cells. Also facilitated is the design of in vitro based screening systems for testing the therapeutic impact and/or toxicity of potential treatment or culture regimes to which thymic epithelial cells may be exposed. In another aspect, the present invention is directed to a method of identifying thymic epithelial cellular subpopulations and, more particularly, thymic epithelial progenitors by screening for the co-expression of markers including MHC Class II, UEA1 and Ly51. This method is useful in a range of applications including, but not limited to, assessing or monitoring for the presence of thymic epithelial cell populations and/or facilitating the isolation of or enrichment for these cellular populations of use in a range of research and clinical applications.	07-15-2010

Ann Chihani, Molnlycke SE

Patent application number	Description	Published
20090020547	Container for a stack of individually removable paper products - A container for a stack of individually removable paper products (	01-22-2009

Ann Christensen, Hoersholm DK

Patent application number	Description	Published
20080312220	Oxadiazole Derivatives with Crth2 Receptor Activity - Compounds of formula are CRTH2 ligands, useful for treatment of inflammatory, autoimmune, respiratory or allergy disease: wherein R	12-18-2008
20090062317	MEDICINAL USE OF RECEPTOR LIGANDS - Compounds of formula (I) are ligands of the melanin concentrating hormone-1 receptor (MCH-1R), useful in the treatment of diseases responsive to modulation of melanin concentrating hormone (MCH) activity, for example feeding disorders and diseases for which obesity is a risk factor (I): wherein ring B is selected from specific substituted phenyl or benz-fused 5 membered N-containing heterocycles defined in the specification; R, is attached to a ring carbon of ring B, and represents hydrogen, F, Cl, or —OCH	03-05-2009

Ann Currylindsay, Courtenay CA

Patent application number	Description	Published
20120009311	PREPARED FOOD PRODUCT, METHOD OF PREPARATION AND BAKING APPARATUS FOR SAID PREPARED FOOD PRODUCT - A method of preparing a food product comprising the steps of obtaining an amount of suitable baking dough; placing the dough on a flat surface and shaping it into a rectangle; placing a suitable amount of flavoured sauce on the top surface of the dough; preparing a food skewer and placing it on the sauce; placing grated cheese on top of the food skewer; folding the dough rectangle partially over the food skewer to form a folded assembled food product. The product can then be baked in an novel baking pan comprising three baking chambers or the product can be frozen for future consumption.	01-12-2012

Ann De Bolster, Leuven BE

Patent application number	Description	Published
20080276000	System and Method for Distributing Content via a Shared Network - Bandwidth use between an access provider system (	11-06-2008

Ann Demirtjis, Redmond, WA US

Patent application number	Description	Published
20090300158	METHOD AND SYSTEM FOR SUPPORTING THE COMMUNICATION OF PRESENCE INFORMATION AMONG COMPUTING DEVICES OF A NETWORK - A method and system for aggregating presence information generated by multiple devices associated with a single user is presented. A server acting as a presence agent on behalf of a first user and the first user's computing device receives and responds to a subscription request generated by a computing device operated by a second user that wishes to be permitted as a watcher of the first user. If the server is not capable of acting as a presence agent, then the first user's computing device assumes the role of a presence agent.	12-03-2009

Ann De Wree, City Outer BE

Patent application number	Description	Published
20090014465	DOSING AND DISPENSING DEVICE - The present invention relates to a dosing and dispensing device (	01-15-2009

Ann Ellerman-Denardo, Pagosa Springs, CO US

Patent application number	Description	Published
20090101366	Homeland fire suppression system - A fire suppression system for effectively subduing fires. The fire suppression system comprises an underground water tank having a first predetermined size specifically calculated to meet the needs of such property to be protected. A pre-charged foam proportioning device containing dry foam powder is engageable with the underground water tank. The system includes a system engageable with such underground water tank and with such foam proportioning device for dispensing a water/foam mixture for such property to be protected.	04-23-2009

Ann Engelkemeir, East Lyme, CT US

Patent application number	Description	Published
20120024204	System and Method for Obtaining Clean Coal Tars from Pyrolized Coal and Biomass - A system and method for collecting hot coal tar gases emanating from a coal containing pyrolytic kiln are described. The hot coal tar gases, comprising a variety of different hydrocarbons as well as inorganic gases arising from the kiln thermal processing are transferred by diffusion and forced convection to a thermal duct in which the temperature is controlled to be maintained at a temperature below that of the kiln. The gaseous hydrocarbon with the highest condensation temperature is the first to liquefy. Additional useful hydrocarbons liquefy as the temperature of the gas continues to cool from the kiln temperature of ˜5000 C to one approaching the minimum duct temperature, ˜175° C. After a number of desirable hydrocarbons present in the coal tar gas have liquefied, the liquid contents are collected, either separately or as a combination of liquid hydrocarbons. The several remaining inorganic and some hydrocarbons gases with condensation temperatures below the minimum duct temperature are separately collected in gaseous form for further processing and/or safe disposal.	02-02-2012

Ann Forret, Longes FR

Patent application number	Description	Published
20110070149	THIN LAYER FIXED BED REACTOR FOR THE CHEMICAL TREATMENT OF A FINELY DIVIDED CATALYTIC SOLID - The present invention describes a thin layer fixed bed reactor intended for chemical treatments, in particular reduction of a Fischer-Tropsch synthesis catalyst. The reactor is designed in the form of similar, compact modules and operates with a ratio of linear pressure drop to outlet pressure which falls within certain limits.	03-24-2011
20110097673	CHEMICAL LOOPING METHOD FOR THE COMBUSTION OF HEAVY LIQUID HYDROCARBON FRACTIONS - The invention relates to a method for upgrading heavy liquid fractions resulting from oil refining, by combustion in a fluidized-bed chemical looping process. The method according to the invention allows to produce energy by oxidizing totally the heavy liquid feeds while allowing direct capture of the CO	04-28-2011
20110171588	OPTIMISED METHOD AND DEVICE LOOP COMBUSTION ON LIQUID HYDROCARBON FEEDSTOCK - The invention relates to a device and to an improved method for chemical looping combustion of at least one liquid hydrocarbon feed, comprising: mixing the liquid feed with an atomization gas so as to feed it into a metal oxide transport zone (	07-14-2011
20110266196	INTEGRATED SEQUENCE OF METHODS FOR EXTRACTING AND PROCESSING EXTRA-HEAVY OR BITUMINOUS CRUDE OIL WITH CO2 CAPTURE - The present invention relates to a method of preparing synthetic crude oil from a heavy crude reservoir, comprising: (a) extracting the heavy crude oil using a steam technology; (b) separating the crude extracted and the water; (c) separating the crude into at least one light cut and one heavy cut; (d) converting said heavy cut to a lighter product and a residue; (e) optionally, partially or totally hydroprocessing the converted product and/or the light cut(s) obtained upon separation (c); (f) burning and/or gasifying the conversion residue in the presence of metal oxides in at least one chemical looping cycle producing CO	11-03-2011
20110303875	INTEGRATED OXIDATION, REDUCTION AND GASIFICATION METHOD FOR CHEMICAL LOOPING SYNGAS AND ENERGY PRODUCTION - The invention relates to an energetically self-sufficient syngas production method in at least one chemical loop. The chemical loop involves at least three distinct oxidation, reduction and gasification reaction zones:	12-15-2011
20120148484	CHEMICAL LOOPING COMBUSTION METHOD AND PLANT WITH INDEPENDENT SOLID CIRCULATION CONTROL - The invention relates to an improved plant and method for chemical looping combustion of at least one hydrocarbon feed with independent control of the circulation of the solid active mass particles between the fluidized bed reaction zones, by means of one or more non-mechanical valves of L-valve type.	06-14-2012
20140155500	INJECTION OF ADDITIVE INTO A UNIT FOR SYNTHESISING HYDROCARBONS STARTING FROM SYNTHESIS GAS ENABLING A HOMOGENOUS CONCENTRATION OF CATALYST TO BE CONTROLLED AND MAINTAINED - The invention relates to a process for synthesising hydrocarbons starting from a feedstock containing synthesis gas. In the process a solid Fischer-Tropsch catalyst is employed in a three-phase reaction section operated so that the catalyst is maintained in suspension in a liquid phase by the circulation of a gaseous phase from the bottom to the top of the reaction section. The process utilizes conditions to control and maintain the homogeneity of the concentration of catalyst particles in the reaction section.	06-05-2014
20150013575	INTEGRATED METHOD FOR GASIFICATION AND INDIRECT COMBUSTION OF SOLID HYDROCARBON FEEDSTOCKS IN A CHEMICAL LOOP - The invention relates to an integrated method for gasification and indirect combustion of a solid hydrocarbon feedstock in a chemical loop, comprising:	01-15-2015

Ann Forsthoefel, Lafayette, CO US

Patent application number	Description	Published
20080222949	Devices and methods for growing plants - A gardening system includes a modular seed cartridge including a rigid, cup-shaped receptacle including an upper portion having an outer rim, a soilless growth medium located in the rigid, cup-shaped receptacle, and at least one seed in contact with the soilless growth medium. The gardening system also includes an aeroponic or hydroponic garden including a chamber including a lower portion for storing a liquid nutrient solution, a cover located above the chamber, the cover including a plant opening adapted to removably support the modular seed cartridge by the outer rim, and a pump located in the chamber and adapted to circulate the liquid nutrient solution from the lower portion of the chamber to the modular seed cartridge supported by the plant opening.	09-18-2008
20080282610	Devices and methods for growing plants - A soilless garden includes a chamber including a sealed lower portion for storing liquid nutrient solution, and an upper portion including a support structure; soilless growth medium supported by the support structure and adapted to support at least one plant having roots; a removable germination cap located above the soilless growth medium; a conduit having a first end located substantially adjacent to the soilless growth medium, and a second end opposite to the first end; and a pump in the chamber, including an input for receiving the liquid nutrient solution from the lower portion of the chamber, and an output to deliver liquid nutrient solution through the conduit into the soilless growth medium. The support structure includes an opening directed toward the lower portion of the chamber for the liquid nutrient solution to drip from the roots of the at least one plant into the lower portion of the chamber.	11-20-2008

Ann Geoncy, Tanzania IN

Patent application number	Description	Published
20120016826	EVOLUTIONARY CLUSTERING ALGORITHM - The invention relates to selecting a set of candidate genes from a pool of genes. The method comprising receiving a set of gene data; arranging the set of gene data into a set of clusters with similar profiles by use of a clustering algorithm; and inputting the set of clusters into a genetic algorithm to select a set of candidate genes from the set of clusters. The method thus relates to hybrid between selection by clustering computation and selection by evolutionary computation. This hybrid is also referred to as an evolutionary clustering algorithm (ECA).	01-19-2012

Ann Gettys, Norman, OK US

Patent application number	Description	Published
20110056489	RESPIRATORY TREATMENT DELIVERY SYSTEM - Embodiments relate to systems and methods for delivery of oxygen or other treatment gases to a patient without requiring physical contact or enclosure of the patient. Embodiments can include a delivery hood, sensing components, and a gas distribution system including one or more gas delivery ports. Gas delivery ports may be individually controlled based on input from the sensing components to alter the volume and orientation of treatment gas flow directed at a patient. Sensing components can include cameras or other sensors that detect the position of a patient's head, and gas delivery ports may then be controlled to direct treatment gas flow in the direction of the patient's head. Embodiments and methods described thereby allow for efficient oxygen or other gas delivery to a patient without requiring contact or enclosure of the patient.	03-10-2011
20130152932	Respiratory Treatment Delivery System - Embodiments relate to systems and methods for delivery of oxygen or other treatment gases to a patient without requiring physical contact or enclosure of the patient. Embodiments can include a delivery hood, sensing components, and a gas distribution system including one or more gas delivery ports. Gas delivery ports may be individually controlled based on input from the sensing components to alter the volume and orientation of treatment gas flow directed at a patient. Sensing components can include cameras or other sensors that detect the position of a patient's head, and gas delivery ports may then be controlled to direct treatment gas flow in the direction of the patient's head. Embodiments and methods described thereby allow for efficient oxygen or other gas delivery to a patient without requiring contact or enclosure of the patient.	06-20-2013

Ann Gryaznova, Petach-Tikva IL

Patent application number	Description	Published
20120168541	METHOD AND APPARATUS FOR MANUFACTURING SUBMICRON POLYMER POWDER - A method and apparatus for manufacturing a submicron polymer powder from solid polymer bodies or coarse particles, preferably of polytetrafluoroethylene powder, wherein powder is ground into fibrous particles in the first stage and is disintegrated into submicron particles by aerodynamic treatment in the second stage, where a gas-particle mixture is subject to the effect of centrifugal forces and suction forces acting in the direction opposite to the centrifugal forces, a pulsating sign-alternating temperature field generated by a pulsed supply of liquid nitrogen, turbulent forces of vortexes, and aerodynamic forces that cause alternating compression and expansion of the gas-particle mixture.	07-05-2012

Ann Hsu, Los Altos Hills, CA US

Patent application number	Description	Published
20100298268	CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF - The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.	11-25-2010
20120177731	CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF - The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.	07-12-2012
20130102676	CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF - The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.	04-25-2013
20130259932	CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF - The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.	10-03-2013
20140018425	CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF - The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.	01-16-2014
20140024718	CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF - The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid. Also provided by this invention is multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.	01-23-2014

Ann Huang, Femont, CA US

Patent application number	Description	Published
20080300616	MECHANICALLY DETACHABLE VASO-OCCLUSIVE DEVICE - A device for delivering an occlusive element includes an elongate pusher member having a lumen extending between distal and proximal ends. An elongate releasing member is slideably disposed within the lumen of the elongate pusher member. A retaining member is disposed on the distal end of the elongate pusher member and includes a finger portion having an aperture sized to receive the distal end of the elongate releasing member. An occlusive element such as a coil is provided and includes a securing member positioned at a proximal end thereof. The securing member is releasably secured to the finger portion of the retaining member. The securing member is secured to the finger portion when the elongate releasing member is disposed in the aperture of the finger portion and unsecured when the elongate releasing member is retracted proximally from the aperture of the finger portion.	12-04-2008

Ann Huletsky, Sillery CA

Patent application number	Description	Published
20080227087	Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx - Described herein are novel SCCmec right extremity junction (MREJ) sequences for the detection and/or identification of methicillin-resistant	09-18-2008
20100267012	Highly conserved genes and their use to generate probes and primers for detection of microorganisms - Compositions and methods for the detection of vancomycin-resistant pathogens using primers and/or probes to the vanA and vanB genes.	10-21-2010
20120035071	HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE PROBES AND PRIMERS FOR DETECTION OF MICROORGANISMS - Compositions and methods for the detection of vancomycin-resistant pathogens using primers and/or probes to the vanA and vanB genes.	02-09-2012
20120058487	COMPOSITIONS AND METHODS FOR DETECTING KLEBSIELLA PNEUMONIAE - Four highly conserved genes, encoding translation elongation factor Tu, translation elongation factor G, the catalytic subunit of proton-translocating ATPase and the RecA recombinase, are used to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis. The detection of associated antimicrobial agents resistance and toxin genes are also under the scope of the present invention.	03-08-2012
20140127684	HIGHLY CONSERVED GENES AND THEIR USE TO GENERATE PROBES AND PRIMERS FOR DETECTION OF MICROORGANISMS - Provided herein are compositions and methods for the detection of	05-08-2014

Ann Huletsky, Quebec CA

Patent application number	Description	Published
20090068641	Highly conserved genes and their use to generate probes and primers for detection of microorganisms - Four highly conserved genes, encoding translation elongation factor Tu, translation elongation factor G, the catalytic subunit of proton-translocating ATPase and the RecA recombinase, are used to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis. The detection of associated antimicrobial agents resistance and toxin genes are also under the scope of the present invention.	03-12-2009
20110294128	Concentration and Enrichment of Microbial Cells and Microbial Nucleic Acids from Bodily Fluids - The present invention relates to a method for isolating microorganisms and/or microorganisms nucleic acids from a bodily fluid that may comprise or may be suspected to comprise microorganisms and/or host cells and/or host cells debris. Microorganisms nucleic acids may further be isolated by lysing the isolated microorganisms. The present invention also relates to a method for detecting microorganisms in a bodily fluid. The present invention further relates to a saponin formulation and its use.	12-01-2011

Ann Hulet-Sky, Quebec CA

Patent application number	Description	Published
20110151453	NUCLEIC ACID SEQUENCES AND COMBINATION THEREOF FOR SENSITIVE AMPLIFICATION AND DETECTION OF BACTERIAL AND FUNGAL SEPSIS PATHOGENS - The present invention relates to methods of detection, as well as assays, reagents and kits for the specific detection of clinically important bacterial and fungal species. The present invention allows for the specific detection of nucleic acids of each of these pathogens in a single assay.	06-23-2011

Ann Husgen, Rochester, MN US

Patent application number	Description	Published
20080305213	METHOD AND COMPOSITION FOR PREPARING CURED MEAT PRODUCTS - The invention provides a curing agent comprising a plant-based nitrite derived from plant material comprising nitrate and a process for preparing the curing agent comprising contacting a plant material with an organism capable of converting nitrate to nitrite. The curing agent can be used to preserve or cure meat or meat products.	12-11-2008
20140242217	Method and Composition for Preparing Cured Meat Products - The invention provides a curing agent comprising a plant-based nitrite derived from plant material comprising nitrate and a process for preparing the curing agent comprising contacting a plant material with an organism capable of converting nitrate to nitrite. The curing agent can be used to preserve or cure meat or meat products.	08-28-2014

Ann Johansson, Lund SE

Patent application number	Description	Published
20100185099	SYSTEM AND METHOD FOR THERAPY AND DIAGNOSIS COMPRISING IN COMBINATION NON-MECHANICAL AND MECHANICAL DISTRIBUTORS FOR DISTRIBUTION OF RADIATION - A system and method for therapy and diagnosis of a human or animal. At least one coupling element for coupling of radiation couples radiation from at least a first radiation source to a tumor site and/or from said second radiation source to said site and/or from said site to a detector. The coupling elements are combinations of at least one translatory distributor, at least one rotary distributor, and at least one operation mode selector means for directing either said therapeutic radiation or said diagnostic radiation to said site through said at least one first radiation conductor. The system may be used for interactive interstitial photodynamic tumor therapy. The system and method according to the invention combines the advantages of purely mechanical and purely non-mechanical solutions in a new and synergetic way.	07-22-2010
20110034971	SYSTEM AND METHOD FOR CONTROLLING AND ADJUSTING INTERSTITIAL PHOTODYNAMIC LIGHT THERAPY PARAMETERS - A method and system for controlling and adjusting light in interstitial photodynamic light therapy (IPDT) in a subject is disclosed. More particularly, a method for controlling the light in interstitial tumor photodynamic light therapy is described using calculation method for determination of status of tissue during the PDT treatment. The status is used in a feedback loop to control the continued PDT treatment. Methods are disclosed that constitute pre-treatment and realtime dosimetry modules for IPDT on the whole prostate glandular tissue. The method includes reconstruction of the target geometry, optimization of source fiber positions within this geometry, monitoring of the light attenuation during the treatment procedure and updating individual fiber irradiation times to take into account any variation in tissue light transmission. A control device that is arranged to restrict delivery of therapeutic light treatment at least temporary in dependence of at least one attribute of one of photodynamic treatment parameters. In comparison to no treatment feedback, a significant undertreatment of the patient as well as damage to healthy organs at risk are avoided.	02-10-2011

Ann Kjersti Fahlvik, Oslo NO

Patent application number	Description	Published
20080319278	Sensor - A physiological sensing device comprises, in combination a sensor (	12-25-2008

Ann Leenaers, Zolder BE

Patent application number	Description	Published
20120207264	COATED NUCLEAR REACTOR FUEL PARTICLES - A method is described for producing nuclear fuel products, including the steps of receiving metallic or intermetallic uranium-based fuel particle cores, providing at least one physical vapour deposited coating layer surrounding the fuel particle core and embedding the nuclear fuel particles in a matrix so as to form a powder mixture of matrix material and coated fuel particles. The at least one physical vapour deposited coating layer may include inhibitors of inhibiting, stabilizing and/or reducing interaction between metallic and intermetallic uranium-based fuel particles cores and the matrix wherein the fuel particles typically may be embedded. The deposited coating layer may include neutron poisons.	08-16-2012

Ann Marie Cannon, Pettigo IE

Patent application number	Description	Published
20090163612	TISSUE ENGINEERING SCAFFOLD - A tissue engineering scaffold for cell, tissue or organ growth comprises a biocompatible porous polyurethane cellular material comprising a plurality of substantially spherical voids of diameter from 20 to 300 microns, preferably 80 to 200 microns, interconnected by generally elliptically shaped pores. The cellular material has a void content of from 85% to 98% and a surface area to volume of from 5 to 400 mm	06-25-2009
20090254115	EMBOLIC PROTECTION SYSTEM - An embolic protection system comprises an embolic protection filter	10-08-2009

Ann Marshak-Rothstein, Newton, MA US

Patent application number	Description	Published
20100203053	METHOD AND COMPOSITION FOR TREATING IMMUNE COMPLEX ASSOCIATED DISORDERS - The present invention provides methods and compositions for treating immune complex associated diseases (ICAD), such as SLE, rheumatoid arthritis, and hepatitis-C related immune complex disease (e.g., cryoglobulinemia) in a subject having an ICAD or at risk for developing ICAD. The invention is based upon the surprising finding that chromatin-containing immune complexes activate autoreactive B cells and dendritic cells by a dual receptor engagement process which, in both cell types, involves a Toll-like receptor (TLR). The methods of treating ICAD comprise administering a compound to an individual in need thereof that either 1) inhibits formation of the immune complex either by preventing formation and/or binding to the TLR, or 2) interferes with binding of an autoantigen-containing immune complex (or the antigenic component thereof) to the TLR, or 3) inhibits signaling pathways initiated by dual engagement of BCR and TLR (in B cells) or FcR and TLR (in dendritic cells) via immune complexed or uncomplexed autoantigens.	08-12-2010

Ann Mcfarren US

Patent application number	Description	Published
20120035949	HEALTHCARE INFORMED CONSENT SYSTEM AND METHODS - A system and methods for creating electronic informed consent documents regarding a healthcare-related research study. Such informed consent documents can include multimedia content to help the prospective participants make an informed decision as to whether or not to participate in the study. In addition to providing easy to understand information about the study, the system can allow prospective participants to store questions and notes, to take one or more tests to assess their understanding of the study, and to walk through a set of psychological, physical, and environmental issues that can help them better assess whether to participate in the study.	02-09-2012

Ann Olincy, Morrison, CO US

Patent application number	Description	Published
20120208718	SCHIZOPHRENIA TREATMENT RESPONSE BIOMARKERS - The present invention provides biomarker of antipsychotic treatment response in patients with schizophrenia and other disorders involving DRD2 and methods for using the same.	08-16-2012

Ann Opsommer, Koninslo BE

Patent application number	Description	Published
20110088597	DURABLE MAGNESIUM OXYCHLORIDE CEMENT AND PROCESS THEREFOR - A magnesium oxychloride cement (MOC) composition comprising:	04-21-2011
20140216653	FIRE PROTECTION MORTAR - A composition for the preparation of a fire protection mortar comprising	08-07-2014

Ann Poblenz, Playa Del Rey, CA US

Patent application number	Description	Published
20090018146	Combination Therapy with Triterpenoid Compounds and Proteasome Inhibitors - The present invention provides therapeutic compositions comprising a natural triterpenoid and a proteasome inhibitor. These compositions will be particularly useful in the treatment of malignancies and inflammation. The present invention also provides methods of treating a subject having a malignancy or an inflammatory disorder comprising administering to the subject a natural triterpenoid and a proteasome inhibitor.	01-15-2009

Ann Progulske-Fox, Gainesville, FL US

Patent application number	Description	Published
20080311596	Genes of Porphyromonas Gingivalis W83 Involved in Invasion of Human Cells - Compositions and methods are provided for detection and treatment of	12-18-2008
20100285012	METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCERS AND PATHOGENIC INFECTIONS - The subject application provides small compounds that are able to suppress autophagy in various cells. These compounds are useful in augmenting the existing treatments of various cancers and microbial/parasitic infections. Thus, the subject application also provides methods of treating various types of cancers and microbial/parasitic infections. Also provided by the subject application are methods of suppressing the expansion of autophagosomes within cells or individuals and inhibiting the lipidation of autophagy-related protein 8 (Atg8).	11-11-2010
20110294146	Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases - Antibodies, polypeptides, and polynucleotides are provided for the detection, prevention, amelioration and treatment of diseases caused by	12-01-2011

Ann Progulske-Fox, Keystone Heights, FL US

Patent application number	Description	Published
20080299591	Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases - The invention provides compositions and methods for the detection of	12-04-2008
20090142782	Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases - Antibodies, polypeptides, and polynucleotides are provided for the detection, prevention, amelioration and treatment of diseases caused by	06-04-2009
20110065132	Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases - Antibodies, polypeptides, and polynucleotides are provided for the detection, prevention, amelioration and treatment of diseases caused by	03-17-2011

Ann Pucar Rimhagen, Motala SE

Patent application number	Description	Published
20100254274	Method of Monitoring Cells in Wireless Communication Systems - A wireless communication network automatically tests itself for sleeping cells. This is done by designing the base stations to regularly act as a terminal, contact its neighboring base stations and as a mobile perform a set of typical traffic cases. From the outcome of the traffic cases the probing base station detects neighboring base stations that cannot carry traffic. The information about sleeping cells is subsequently communicated from the base station to the operation and maintenance system.	10-07-2010

Ann Racuya-Robbins, Espanola, NM US

Patent application number	Description	Published
20110004482	System for Knowledge Creation - In order to establish a system that maximizes the creation and benefits of human knowledge for the most people, including the wealth knowledge generates, the nature of the knowledge creation process itself must be understood and embedded in the system. The invention is the system for enabling knowledge creation and the wealth knowledge generates in which participants retain ownership to his or her knowledge and most of the wealth the knowledge generates.	01-06-2011

Ann Reitnauer, Keene, NH US

Patent application number	Description	Published
20090181222	HOT MELT INKS - A method for forming a mark on a substrate is disclosed. The method includes: (a) heating an edible hot melt ink including a colorant to a temperature sufficient to liquify the ink; and (b) transferring the ink to a substrate to provide a mark on the substrate.	07-16-2009

Ann Samenuk, Ridgefield, CT US

Patent application number	Description	Published
20120171647	DINING PLATE AND METHOD FOR USE IN A DIET - A dining plate includes a top portion with a substantially transparent window therein. The plate also includes a bottom portion with a bottom surface having a first outside receiving groove and second inside receiving groove. The bottom portion has a generally planar shape that corresponds generally to the shape of the top portion. The bottom portion also has a top surface with a continuous inner standing rib and an outward rim. The top and bottom portions are joined together so that the inner standing rib is releaseably positioned in the inside receiving groove and the outward rim is releaseably positioned in the outside receiving groove. A substantially watertight cavity is formed between a central section of each of the top and bottom portions. The cavity is aligned with the window in the top portion.	07-05-2012

Ann Shen, Saratoga, CA US

Patent application number	Description	Published
20090079497	PHASE TUNING TECHNIQUES - A differential frequency divider includes first and second input terminals each configured to receive a differential input signal. The divider also includes a first output terminal configured to produce a first output signal and a second output terminal configured to produce a second output signal. The divider further includes a third input terminal coupled to the first output terminal and a fourth input terminal coupled to the second output terminal. In addition, the divider includes a first variable current source. Altering a current of the first variable current source causes a change in the phase difference between a first output signal of the first output terminal and a second output signal of the second output terminal.	03-26-2009

Ann Shimakawa, Palo Alto, CA US

Patent application number	Description	Published
20100244822	METHOD AND SYSTEM TO PERFORM PHASE CORRECTION FOR SPECIES SEPARATION IN MAGNETIC RESONANCE IMAGING - Methods and systems are provided for processing a magnetic resonance images. In one embodiment, first and second sets of lines of magnetic resonance imaging signals are acquired. The acquired sets of lines have readout gradients that are reversed in polarity with respect to one another. A two-dimensional phase error is determined using the first and second set of lines.	09-30-2010

Ann Skudlark, Westfield, NJ US

Patent application number	Description	Published
20100057560	Methods and Apparatus for Individualized Content Delivery - Systems and techniques for predicting customer response to content and selecting content for delivery to particular customers in accordance with the predictions. As information is delivered to and received from a plurality of customers over multiple communication channels, data streams representing communications between providers and customers are analyzed and selected data extracted therefrom. Linkages are created between data collected from the different channels and data are anonymized. The data are analyzed to create a customer response predictor for each customer that models customer behavior and predicts customer response to advertisements. As content, such as advertisements, are to be delivered to a destination, information from a predictor created using data collected from a customer associated with the destination is used to select appropriate content.	03-04-2010

Ann Sydeman, Woodside, CA US

Patent application number	Description	Published
20110291964	Apparatus and Method for Gesture Control of a Dual Panel Electronic Device - An electronic device includes a processor, a first touch screen and a second touch screen. The first touch screen displays an object. An object transition module executed by the processor includes executable instructions to map a gesture applied to the object to a set of object movement parameters and then move the object from the first touch screen to the second touch screen in accordance with the object movement parameters.	12-01-2011
20110291969	Apparatus and Method for Right/Left Hand Orientation of a Dual Panel Electronic Device - An electronic device includes a processor, a first touch screen displaying a page for reading and a second touch screen displaying a pad for writing. An object transition module is executed by the processor. The object transition module includes executable instructions to detect a rotational input applied to the pad. The pad is rotated in accordance with the rotational input, while the original orientation of the page is maintained.	12-01-2011
20110296344	Apparatus and Method for Digital Content Navigation - An electronic device includes a processor, a memory for storing digital content and a display. The processor forms a content navigation bar for the digital content. The content navigation bar is rendered on the display and includes a first section marker corresponding to a first section of the digital content. A set of page markers corresponds to pages within the first section of the digital content. The set of page markers includes a boundary page marker. A second section marker is adjacent to the boundary page marker.	12-01-2011

Ann Syrdal, Morristown, NJ US

Patent application number	Description	Published
20080226256	Systems and methods of providing modified media content - A method of providing modified media content is disclosed that includes providing media content to a destination device via a network, where the media content comprises video data and audio data have a first viewing rate. The method further includes receiving data indicating a selection of a second viewing rate via the network and modifying the media content to produce modified media content having approximately the second viewing rate. The modified media content includes modified video data and modified audio data synchronized at approximately the second viewing rate.	09-18-2008
20080235741	Systems and Methods of providing modified media content - A method and system of providing media content is disclosed. In a particular embodiment, the method includes receiving media content from a content source at a set-top box device. The media content includes video data having a first playback rate and audio data having the first playback rate. The method further includes transforming the audio data via a non-linear transformation to produce modified audio data having a second playback rate, modifying the video data to produce modified video data having the second playback rate, and synchronizing the modified audio data and the modified video data to produce modified media content having the second playback rate. A network-based media content storage device and associated logic to provide adjusted rate audio content are also disclosed.	09-25-2008
20130051753	Systems and Methods of Providing Modified Media Content - A method includes processing media content. The media content includes audio data corresponding to a first audio playback rate and video data corresponding to a first video playback rate. Processing the media content includes identifying a speech portion of the audio data. The speech portion includes a consonant portion. The method further includes producing modified media content. The modified media content is produced based on modifying the video data and modifying the audio data. Modifying the audio data includes applying a non-linear transformation to the speech portion identified in the audio data. The method further includes storing the modified media content.	02-28-2013
20130216210	Systems and Methods of Providing Modified Media Content - In a particular embodiment, a method includes displaying a playback rate slide bar having a plurality of increments. The plurality of increments is equally spaced along the playback rate slide bar and each increment of the plurality of increments corresponds to a different playback rate of media content.	08-22-2013

Ann Tatoian, Glendora, CA US

Patent application number	Description	Published
20110046588	REMOVABLE ABSORBENT PAD FOR TRANSPORTER - An absorbent pad that can be removably connected to a transporter on which an injured person is carried is provided. Structures for removably attaching the absorbent pad to the transporter are described. Also provided are a transporter having a removable absorbent pad and a method for placing a removable absorbent pad on a transporter.	02-24-2011

Ann Thanawastien, Pembroke, MA US

Patent application number	Description	Published
20120231086	PROTEIN MATRIX VACCINES OF IMPROVED IMMUNOGENICITY - The present invention relates to immunogenic compositions containing an antigen of interest entrapped with a crosslinked carrier protein matrix, methods of making such vaccines, and methods of vaccine administration, wherein the immunogenicity of the protein matrix, and hence its effectiveness as a vaccine, is improved by controlling or selecting the particle size of the protein matrix particles to eliminate low molecular weight particles, e.g., less than 100 nm in diameter.	09-13-2012

Ann Tisthammer, Phoenix, AZ US

Patent application number	Description	Published
20110139155	METHODS AND APPARATUS FOR MONITORING THE CARDIOVASCULAR CONDITION OF PATIENTS WITH SLEEP DISORDERED BREATHING - A method for relating to each other cardiovascular and sleep disordered breathing conditions of a patient. The patient's heart rate and/or detailed echocardiogram data is monitored and recorded continuously or periodically together with sleep disordered breathing information on similar time scales. Changes in the patient's heart rate associated with changes in sleep disordered breathing can then be observed. More specifically, positive airway pressure at therapeutic levels for treatment of sleep disordered breathing is applied while events associated with the treatment of the patient's sleep disordered breathing are detected and recorded. At the same time, information concerning the cardiovascular condition of the patient is stored and the stored information concerning the cardiovascular condition of the patient and the recorded events associated with the treatment of the patient's sleep disordered breathing are related to each other.	06-16-2011
20130331713	METHODS AND APPARATUS FOR MONITORING THE CARDIOVASCULAR CONDITION OF PATIENTS WITH SLEEP DISORDERED BREATHING - An apparatus for assessing patient breathing and cardiovascular condition of a patient includes a storage medium for storing data regarding the breathing and cardiovascular condition of the patient, a processor in communication with the storage medium, the processor being configured to prompt the patient with a series of queries relating to patient breathing and cardiovascular condition, a display for presenting the patient with the series of queries and a date entry device for receiving responses to the series of queries. The processor is configured to tally positive responses to the series of queries to generate a sleep disordered breathing index.	12-12-2013

Ann Ureneck, Red Bank, NJ US

Patent application number	Description	Published
20110268675	Cosmetic Composition Using Low Molecular Weight Dimethicone - Cosmetic compositions which include low molecular weight non-volatile oils, such as dimethicone, along with silica and a volatile solvent are provided. Such compositions exhibit surprisingly beneficial properties such as long wear, resistance to color transfer, low tack and excellent comfort and shine.	11-03-2011

Ann Vanderborght, Hasselt BE

Patent application number	Description	Published
20090074773	CANCER VACCINE - The invention relates generally to the field of cancer diagnosis, prognosis, treatment and prevention. More particularly, the present invention relates to methods of diagnosing, treating and preventing lung cancer. In particular, aspects of the invention are directed to methods of diagnosing, treating and preventing small cell lung cancers. Methods of using a nucleic acid and/or a protein, which are differentially expressed in tumor cells, and antibodies immunospecific for the protein, to treat, diagnose and/or prevent said cancers, are provided for by the present invention.	03-19-2009

Ann Vander Borght, Hasselt BE

Patent application number	Description	Published
20110053156	SMALL CELL LUNG CARCINOMA BIOMARKER PANEL - The invention relates generally to the field of cancer detection, diagnosis, subtyping, staging, prognosis, treatment and prevention. More particularly, the present invention relates to methods for the detection, and/or diagnosing and/or subtyping and/or staging of lung cancer in a patient. Based on a particular panel of biomarkers, the present invention provides methods to detect, diagnose at an early stage and/or differentiate small cell lung cancer (SCLC) from non-small cell lung cancer (NSCLC) and within NSCLC to differentiate between squamous cell carcinomas (SCC), adenocarcinomas (AC), within SCC to discriminate G2 and G3 stage and within lung cancer to differentiate for lung cancers with or without neuroendocrine origin. It further provides the use of said panel of biomarkers in monitoring disease progression in a patient, including both in vitro and in vivo imaging techniques. The in vitro imaging techniques typically include an immunoassay detecting protein or antibody of the biomarkers on a sample taken from said patient, e.g. serum or tissue sample. The in vivo imaging techniques typically include chest radiographs (X-rays), Computed Tomography (CT) imaging, spiral CT, Positron Emission Tomography (PET), PET-CT and scintigraphy for molecular imaging and diagnosis and to monitor disease progression and treatment response in patients. It is accordingly a further aspect to provide a kit to perform the aforementioned diagnosing and/or subtyping and/or staging assay and the imaging techniques, comprising reagents to determine the gene expression or protein level of the aforementioned panel of biomarkers for in vitro and in vivo applications.	03-03-2011

Ann Vorwald, Ames, IA US

Patent application number	Description	Published
20110104201	Porcine Reproductive and Respiratory Syndrome Vaccine Based on Isolate JA-142 - Substantially avirulent forms of atypical porcine reproductive and respiratory syndrome (PRRS) virus and corresponding vaccines are provided which result from cell culture passaging of virulent forms of PRRS. The resultant avirulent atypical PRRS virus is useful as a vaccine in that PRRS specific antibody response is elicited by inoculation of host animals, thereby conferring effective immunity against both previously known strains of PRRS virus and newly isolated atypical PRRS virus strains. The preferred passaging technique ensures that the virus remains in a logarithmic growth phase substantially throughout the process, which minimizes the time required to achieve attenuation. The present invention also provides diagnostic testing methods which can differentiate between animals infected with field strains and attenuated strains of PRRSV.	05-05-2011

Ann Waldhauer, La Honda, CA US

Patent application number	Description	Published
20120000528	METHOD OF FABRICATING A SOLAR CELL WITH A TUNNEL DIELECTRIC LAYER - Methods of fabricating solar cells with tunnel dielectric layers are described. Solar cells with tunnel dielectric layers are also described.	01-05-2012
20120073650	METHOD OF FABRICATING AN EMITTER REGION OF A SOLAR CELL - Methods of fabricating emitter regions of solar cells are described. Methods of forming layers on substrates of solar cells, and the resulting solar cells, are also described.	03-29-2012
20120204926	PROCESS AND STRUCTURES FOR FABRICATION OF SOLAR CELLS - Contact holes of solar cells are formed by laser ablation to accommodate various solar cell designs. Use of a laser to form the contact holes is facilitated by replacing films formed on the diffusion regions with a film that has substantially uniform thickness. Contact holes may be formed to deep diffusion regions to increase the laser ablation process margins. The laser configuration may be tailored to form contact holes through dielectric films of varying thicknesses.	08-16-2012
20130078758	METHOD OF FABRICATING A SOLAR CELL WITH A TUNNEL DIELECTRIC LAYER - Methods of fabricating solar cells with tunnel dielectric layers are described. Solar cells with tunnel dielectric layers are also described.	03-28-2013
20140096824	PROCESS AND STRUCTURES FOR FABRICATION OF SOLAR CELLS - Contact holes of solar cells are formed by laser ablation to accommodate various solar cell designs. Use of a laser to form the contact holes is facilitated by replacing films formed on the diffusion regions with a film that has substantially uniform thickness. Contact holes may be formed to deep diffusion regions to increase the laser ablation process margins. The laser configuration may be tailored to form contact holes through dielectric films of varying thicknesses.	04-10-2014
20140134788	METHOD OF FABRICATING A SOLAR CELL WITH A TUNNEL DIELECTRIC LAYER - Method of fabricating solar cells with tunnel dielectric layers are described. Solar cells with tunnel dielectric layers are also described.	05-15-2014
20140166093	SOLAR CELL EMITTER REGION FABRICATION USING N-TYPE DOPED SILICON NANO-PARTICLES - Methods of fabricating solar cell emitter regions using N-type doped silicon nano-particles and the resulting solar cells are described. In an example, a method of fabricating an emitter region of a solar cell includes forming a plurality of regions of N-type doped silicon nano-particles on a first surface of a substrate of the solar cell. A P-type dopant-containing layer is formed on the plurality of regions of N-type doped silicon nano-particles and on the first surface of the substrate between the regions of N-type doped silicon nano-particles. At least a portion of the P-type dopant-containing layer is mixed with at least a portion of each of the plurality of regions of N-type doped silicon nano-particles.	06-19-2014
20140170800	SOLAR CELL EMITTER REGION FABRICATION USING SILICON NANO-PARTICLES - Methods of fabricating solar cell emitter regions using silicon nano-particles and the resulting solar cells are described. In an example, a method of fabricating an emitter region of a solar cell includes forming a region of doped silicon nano-particles above a dielectric layer disposed above a surface of a substrate of the solar cell. A layer of silicon is formed on the region of doped silicon nano-particles. At least a portion of the layer of silicon is mixed with at least a portion of the region of doped silicon nano-particles to form a doped polycrystalline silicon layer disposed on the dielectric layer.	06-19-2014
20140295609	SOLAR CELL EMITTER REGION FABRICATION USING SILICON NANO-PARTICLES - Methods of fabricating solar cell emitter regions using silicon nano-particles and the resulting solar cells are described. In an example, a method of fabricating an emitter region of a solar cell includes forming a region of doped silicon nano-particles above a dielectric layer disposed above a surface of a substrate of the solar cell. A layer of silicon is formed on the region of doped silicon nano-particles. At least a portion of the layer of silicon is mixed with at least a portion of the region of doped silicon nano-particles to form a doped polycrystalline silicon layer disposed on the dielectric layer.	10-02-2014

Ann Westerholm-Parvinen, Vtt FI

Patent application number	Description	Published
20100209985	NOVEL ESTERASES AND THEIR USE - The present invention relates to polyesterases having cutinase and/or suberinase activity obtainable from	08-19-2010

Ann Witvrouw, Herent BE

Patent application number	Description	Published
20100032812	Method for forming silicon germanium layers at low temperatures, layers formed therewith and structures comprising such layers - A method is provided for controlling the average stress and the strain gradient in structural silicon germanium layers as used in micromachined devices. The method comprises depositing a single silicon germanium layer on a substrate and annealing a predetermined part of the deposited silicon germanium layer. The process parameters of the depositing and/or annealing steps are selected such that a predetermined average stress and a predetermined strain gradient are obtained in the predetermined part of the silicon germanium layer. Preferably a plasma assisted deposition technique is used for depositing the silicon germanium layer, and a pulsed excimer laser is used for local annealing, with a limited thermal penetration depth. Structural silicon germanium layers for surface micromachined structures can be formed at temperatures substantially below 400° C., which offers the possibility of post-processing micromachined structures on top of a substrate comprising electronic circuitry such as CMOS circuitry. Such structural silicon germanium layers may be also be formed at temperatures not exceeding 210° C., which allows the integration of silicon germanium based micromachined structures on substrates such as polymer films.	02-11-2010
20100062224	METHOD FOR MANUFACTURING A MICROMACHINED DEVICE - The present invention provides a method for manufacturing micromachined devices on a substrate (	03-11-2010
20100210073	Method for Encapsulating a Device in a Microcavity - Manufacturing a semiconductor device involves forming (	08-19-2010
20110127650	Method of Manufacturing a Semiconductor Device and Semiconductor Devices Resulting Therefrom - A method is disclosed for manufacturing a semiconductor device, including providing a substrate comprising a main surface with a non flat topography, the surface comprising at least one substantial topography variation, forming a first capping layer over the main surface such that, during formation of the first capping layer, local defects in the first capping layer are introduced, the local defects being positioned at locations corresponding to the substantial topography variations and the local defects being suitable for allowing a predetermined fluid to pass through. Associated membrane layers, capping layers, and microelectronic devices are also disclosed.	06-02-2011
20110163399	Method for Manufacturing Microelectronic Devices and Devices According to Such Methods - A method is disclosed for manufacturing a sealed cavity in a microelectronic device, comprising forming a sacrificial layer at least at locations where the cavity is to be provided, depositing a membrane layer over the top of the sacrificial layer, patterning the membrane layer in at least two separate membrane layer blocks, removing the sacrificial layer through the membrane layer, and sealing the cavity by sealing the membrane layer, wherein patterning the membrane layer is performed after removal of the sacrificial layer.	07-07-2011
20110180886	Method for Manufacturing a Micromachined Device and the Micromachined Device Made Thereof - Methods for manufacturing micromachined devices and the devices obtained are disclosed. In one embodiment, the method comprises providing a structural layer comprising an amorphous semiconductor material, forming a shielding layer on a first portion of the structural layer and leaving exposed a second portion of the structural layer, and annealing the second portion using a first fluence. The method further comprises removing the shielding layer, and annealing the first portion and the second portion using a second fluence that is less than half the first fluence. In an embodiment, the device comprises a substrate layer, an underlying layer formed on the substrate layer, and a sacrificial layer formed on only a portion of the underlying layer. The device further comprises a structural layer that is in contact with the underlying layer and comprises a first region annealed using a first fluence and a second region annealed using a second fluence.	07-28-2011
20110180943	Thin Film Wafer Level Package - Anchor designs for thin film packages are disclosed that, in a preferred embodiment are a combination of SiGe-filled trenches and Si-oxide-filled spacing. Depending on the release process, additional manufacturing process steps are performed in order to obtain a desired mechanical strength. For aggressive release processes, additional soft sputter etch and a Ti—TiN interlayer in the anchor region may be added. The ratio of the total SiGe—SiGe anchor area to the SiO	07-28-2011
20110315951	METHOD FOR FORMING A CATALYST SUITABLE FOR GROWTH OF CARBON NANOTUBES - The present disclosure is related to a method for forming a catalyst nanoparticle on a metal surface, the nanoparticle being suitable for growing a single nanostructure, in particular a carbon nanotube, the method comprising at least the steps of: providing a substrate, having a metal layer on at least a portion of the substrate surface, depositing a sacrificial layer at least on the metal layer, producing a small hole in the sacrificial layer, thereby exposing the metal layer, providing a single catalyst nanoparticle into the hole, removing the sacrificial layer. The disclosure is further related to growing a carbon nanotube from the catalyst nanoparticle.	12-29-2011

Ann Zabierek, Watertown, MA US

Patent application number	Description	Published
20110112081	INHIBITORS OF JANUS KINASES - The instant invention provides for compounds that inhibit the four known mammalian JAK kinases (JAK1, JAK2, JAK3 and TYK2). The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting the activity of JAK1, JAK2, JAK3 and TYK2 by administering the compound to a patient in need of treatment for myeloproliferative disorders or cancer.	05-12-2011